Antibody Treatment for Advanced Celiac Disease

Clinical trial NCT01893775 · COMPLETED

Trial details

NCT number: NCT01893775
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Celiac Disease Celiac Sprue Gluten Enteropathy Gluten-Sensitive Enteropathy

Start date: 2013-06-12
Primary completion: 2019-12-20
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.